Interventions for reducing hepatitis C infection in people who inject drugs

The first global review to quantify the impact of needle syringe programs (NSP) and opioid substitution treatment (OST) in reducing the risk of becoming infected with the hepatitis C virus has now been published. The study has implications for millions of people who are ‘at risk’ from infection.